Articles written by linda a. johnson
Sorted by date Results 51 - 75 of 75
By 
FDA asks drugmaker to stop selling its opioid painkiller
TRENTON, N.J. (AP) — U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop s...
Tests for lead poisoning may be faulty, US regulators warn
U.S. health agencies on Wednesday warned that certain blood tests for lead poisoning may give results lower than the actual level of lead. As a result, some children under 6, along with pregnant and nursing women, may need retesting, the Food and...
Does baby powder cause cancer? Another jury says yes.
TRENTON, N.J. (AP) — Johnson & Johnson has been hit with a multimillion-dollar jury verdict for the fourth time over whether the talc in its iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene. Late Thursday, a St. L...
New deals for drugs: No heart attack or your money back
TRENTON, N.J. (AP) — Warranties and money-back guarantees, long used to entice buyers of products like hand tools and kitchen gadgets, are now being used to sell something more crucial: pricey new-generation drugs for diseases like rheumatoid a...
FDA OKs immune-boosting drug for advanced bladder cancer
TRENTON, N.J. (AP) — U.S. regulators have approved a new drug that harnesses the immune system to treat bladder cancer that has spread after chemotherapy or surgery. The Food and Drug Administration on Monday approved Imfinzi for advanced bladder c...
FDA approves 1st targeted drug for certain leukemia patients
U.S. regulators Friday approved the first targeted drug for certain patients with an aggressive form of leukemia. The Food and Drug Administration approved the drug for adults with acute myeloid leukemia, or AML, who have a genetic mutation called...
FDA: Avoid fake 'miracle' cancer treatments sold on internet
TRENTON, N.J. (AP) — U.S. regulators are warning consumers to avoid 65 bogus products hawked on the internet with false claims that they can cure, treat, diagnose or prevent cancer. The Food and Drug Administration says these products , mostly sold o...
FDA further restricts pain medication use in kids
TRENTON, N.J. (AP) — U.S. regulators are strengthening warnings about the dangers of two types of powerful painkillers due to risks of slowed breathing and death. The Food and Drug Administration said Thursday it is requiring makers of p...
FDA approves 2nd near-copy of Remicade for immune disorders
Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders. The U.S. Food and Drug Administration approved Renflexis, developed by...
Hyland's teething tablets recalled over levels of toxic herb
The maker of Hyland's teething tablets has issued a recall for any remaining packages at the urging of U.S. regulators, who say the medicine has inconsistent levels of a herb that can be poisonous. Standard Homeopathic Co. of Los Angeles, stopped...
1st drug OK'd for movement disorder caused by certain meds
TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for treating a neurological syndrome that causes uncontrollable body movements that can also interfere with speech, swallowing and breathing. The sometimes-disabling disorder, tardive...
Mallinckrodt to pay $35M in deal to end feds' opioid probe
TRENTON, N.J. (AP) — A top maker of brand-name and generic narcotic painkillers has agreed to pay the U.S. government $35 million to resolve a probe of its distribution of those drugs. Mallinckrodt PLC said Monday it has reached an agreement with t...
FDA approves 1st drug for aggressive multiple sclerosis
TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus late Tuesday after a large s...
FDA approves 1st drug for moderate & severe eczema cases
TRENTON, N.J. (AP) — U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes re...
FDA links very rare cancer, 9 deaths, to breast implants
Nine deaths from a very rare kind of cancer have been linked to breast implants, indicating a very low but increased risk in women with implants, according to the U.S. Food and Drug Administration. The FDA said it now agrees with the World Health Org...
FDA OKs new drug as add-on treatment for Parkinson's
TRENTON, N.J. (AP) — U.S. regulators have approved the first new drug in a decade for Parkinson's disease, a chronic neurological disorder that causes tremors and movement difficulties. The Food and Drug Administration said Tuesday that it has a...
FDA OKs new Novartis drug for type of advanced breast cancer
TRENTON, N.J. (AP) — U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali and developed by Swiss drugmaker Novartis AG, is a pill that works to s...
FDA issues warning about risky vein opening procedure
TRENTON, N.J. (AP) — The Food and Drug Administration on Wednesday again warned patients and doctors to avoid a risky, experimental procedure promoted as a treatment for several nervous system disorders, including multiple sclerosis and P...
Drugmakers pledge restraint, but prices will still soar
TRENTON, N.J. (AP) — Several big drugmakers are trying to quell the furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases. No one should expect to be paying less for medicine a...
How to improve your sex life without breaking the bank
TRENTON, N.J. (AP) — For many older couples, fun in the bedroom requires help from prescription drugs, but prices of popular brand-name sexual dysfunction drugs have tripled since 2010 and insurance coverage is spotty. Doctors who specialize in t...
Does baby powder cause cancer? Another jury says yes.
TRENTON, N.J. (AP) — For the third time, Johnson & Johnson has been hit with a multimillion-dollar jury verdict over whether the talc in its iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene. Late Thursday, a St. L...
Mylan to pay $465M settlement over Medicaid EpiPen rebates
Drugmaker Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen, ending one of the controversies over the soaring price of the emergency allergy injection. The settlement with the Department of...
Research finds talc doesn't cause cancer; juries disagree
TRENTON, N.J. (AP, posted Sept. 26, 2016) — Two lawsuits ended in jury verdicts worth $127 million. Two others were tossed out by a judge who said there wasn't reliable evidence that the talc in Johnson & Johnson's iconic baby powder causes o...
Insider Q&A: Why so little relief on pricey biologic drugs
Drugs made from living cells, instead of by mixing chemicals, have brought major advances since the late 1990s to the treatment of various cancers, immune system disorders, growth hormone deficiency and eye diseases. But the drugs, called biologics,...
Bayer buying Monsanto, will create global chemical, ag giant
American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer are combining in a deal that could help farmers produce higher yields to address challenges from global warming to rising food demand from a...
